Atlas Trials

A Treatment Extension Study of Mucopolysaccharidosis Type IIIB

Clinical trial NCT03784287 · UNKNOWN

Trial details

NCT number
NCT03784287
Sponsor
Allievex Corporation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis Type IIIBMPS III B
Start date
2018-02-19
Primary completion
2025-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.